DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Myozyme (Alglucosidase Alfa) - Current Clinical Trials

 
 



Myozyme Related Clinical Trials

Immune Tolerance Induction Study [Recruiting]

A Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe Disease [Completed]

An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease [Completed]

A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Patients With Infantile-Onset Pompe Disease Who Have Never Been Treated [Completed]

Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease [Completed]

Late-Onset Treatment Study Extension Protocol [Completed]

Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa [Completed]

High Dose or High Dose Frequency Study of Alglucosidase Alfa [Completed]

Alglucosidase Alfa Pompe Safety Sub-Registry [Recruiting]

Pompe Lactation Sub-Registry [Recruiting]

A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe Disease [Completed]

Pompe Pregnancy Sub-Registry [Recruiting]

Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease [Approved for marketing]

Pharmacokinetics of Alglucosidase Alfa in Patients Aged 8-18 Years of Age [Recruiting]

Alglucosidase Alfa Temporary Access Program [Approved for marketing]

Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving Myozyme® [Completed]

Growth and Development Study of Alglucosidase Alfa. [Active, not recruiting]

rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease) [Completed]

A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease [Completed]

Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease [Recruiting]

Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease [Completed]

A Study of rhGAA in Patients With Late-Onset Pompe Disease [Completed]

Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602 [Completed]

Safety and Effectiveness Study of rhGAA in Patients With Advanced Late-Onset Pompe Disease Receiving Respiratory Support [Completed]

A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II [Completed]

Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients. [Completed]

Drug-drug Interaction Study [Completed]

Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease [Completed]

Pompe Disease Registry [Recruiting]

BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study) [Recruiting]

NeoGAA Extension Study [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015